130820-51-8

Basic information

• Product Name: (2E)-1-(3-methoxyphenyl)-3-(4-methoxyphenyl)prop-2-en-1-one
• Synonyms: (2E)-1-(3-methoxyphenyl)-3-(4-methoxyphenyl)prop-2-en-1-one
• CAS NO: 130820-51-8
• Molecular Weight: 268.312
• Mol File: 130820-51-8.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: (2E)-1-(3-methoxyphenyl)-3-(4-methoxyphenyl)prop-2-en-1-one(CAS DataBase Reference)
• NIST Chemistry Reference: (2E)-1-(3-methoxyphenyl)-3-(4-methoxyphenyl)prop-2-en-1-one(130820-51-8)
• EPA Substance Registry System: (2E)-1-(3-methoxyphenyl)-3-(4-methoxyphenyl)prop-2-en-1-one(130820-51-8)

Safety Data

• Hazardous Substances Data: 130820-51-8(Hazardous Substances Data)

Upstream product

• 123-11-5 4-methoxy-benzaldehyde 
• 586-37-8 1-(3-Methoxyphenyl)ethanone 

Downstream Products

• 1400633-28-4 4-(3-(3-methoxyphenyl)-5-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl)benzoic acid 
• 898775-54-7 1-(3-methoxyphenyl)-3-(4-methoxyphenyl)propan-1-one 
• 74973-33-4 2-(4-methoxyphenyl)cyclopropyl(3-methoxyphenyl)methanone 
• 1122659-72-6 3-(3-methoxyphenyl)-5-(4-methoxyphenyl)isoxazole 
• 1122659-70-4 2,3-Dibromo-1-(3-methoxyphenyl)-3-(4-methoxyphenyl)propan-1-one 
• 857544-02-6 4-(3-methoxy-phenyl)-2-(4-methoxy-phenyl)-4-oxo-butyric acid amide 
• 205752-03-0 2-(4-Methoxyphenyl)-4-(3-Methoxyphenyl)butyric Acid 
• 35947-40-1 4-(3-methoxy-phenyl)-2-(4-methoxy-phenyl)-4-oxo-butyric acid 
• 130820-55-2 6-Methoxy-3-(4-methoxy-phenyl)-indan-1-one 

Relevant articles and documents

Discovery of fluorescent cyanopyridine and deazalumazine dyes using small molecule macroarrays

Small molecule macroarrays of cyanopyridines and deazalumazines were generated in high purities via spatially addressed synthesis on planar cellulose supports. Examination of the spectral properties of the heterocycles both on and off of the planar suppor

In vitro photodynamic treatment of cancer cells induced by aza-BODIPYs

Two aza-BODIPY photosensitizers (PSs, compounds 7 and 8), featuring an iodine atom on each pyrrolic unit of their structure, were synthesized in fairly good yields starting from commercial products and tested in vitro on two human cancer cell lines (HCT11

17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITORS FOR THE TREATMENT OF HORMONE-RELATED DISEASES

The invention relates to 17beta-hydroxysteroid dehydrogenase type 1 (17betaHSD1) inhibitors, the preparation thereof and the use thereof for the treatment and prophylaxis of hormone-related, especially estrogen-related or androgen-related, diseases.